Cited by 54Stress Responses and CortisolNeuroscience and Neuropharmacology ResearchNeuropeptides and Animal Physiology

Endogenous activation of group-II metabotropic glutamate receptors inhibits the hypothalamic–pituitary–adrenocortical axis

Scaccianoce, S., Matrisciano, F., Del Bianco, P., Caricasole, A., Di Giorgi Gerevini, V., Cappuccio, I., Melchiorri, D., Battaglia, G. +1 more·2003·Neuropharmacology

Abstract

Systemic injection of the mGlu2/3 receptor antagonist, LY341495 (1 mg/kg, i.p.), increased plasma corticosterone in mice to an extent similar to that induced by the despair test. Treatment with the mGlu2/3 receptor agonist, LY379268 (1 mg/kg, i.p.), or the non-competitive mGlu5 receptor antagonist, MPEP (5 mg/kg, i.p.), failed to induce significant changes in corticosterone levels. Searching for a site of action of LY341495, we examined the expression of mGlu receptor subtypes in the various anatomical regions of the mouse hypothalamic-pituitary-adrenal (HPA) axis. Only mGlu5 and -7 receptor mRNAs were detected in the adrenal gland by RT-PCR, whereas mGlu -1, -3, -4, -5, -7 and -8 receptor mRNAs were detected in the anterior pituitary. All transcripts (with the exception of mGlu5 and mGlu6 receptor mRNAs) were detected in the hypothalamus. However, Western blot analysis showed the presence of mGlu2/3 receptor proteins only in the hypothalamus and not in the anterior pituitary. This was consistent with functional data showing that LY341495 (0.1 and 1 microM) failed to affect ACTH secretion from isolated mouse anterior pituitaries. Moving from these observations, we examined whether LY341495 could activate the HPA axis by inhibiting mGlu2/3 receptors at hypothalamic level. We measured the release of corticotropin releasing hormone (CRH) in isolated mouse hypothalami incubated in the presence of subtype-selective mGlu receptor agonists or antagonists. Among all the drugs we have tested, only LY341495 was able to increase CRH secretion. With high concentrations of LY341495 (1 microM) this increase was similar to that induced by 50 mM K(+). The action of LY341495 was prevented by the combined application of the mGlu2/3 receptor agonist, LY379268. We conclude that group-II mGlu receptors tonically regulate the HPA axis by controlling CRH secretion at hypothalamic level.

Integrity signals

Registry

Crossref · 10.1016/s0028-3908(03)00027-3

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mice administered with Group II antagonists in vivo experienced an increase in corticosterone that mimicked the response to the forced-swim test.

    “Mice administered with Group II antagonists in vivo experienced an increase in corticosterone that mimicked the response to the forcedswim (behavioral despair) test (Scaccianoce et al., 2003).”

    From Glutamate receptors in domestication and modern human evolution (2020) · cites this paper as Scaccianoce et al., 2003

  • In vitro antagonism of Group II metabotropic receptors in hypothalamic slices increases CRH signaling, whereas no other metabotropic receptor agonists or antagonists had this effect.

    “In vitro antagonism of Group II metabotropic receptors in hypothalamic slices has been shown to increase CRH signaling, whereas no other metabotropic receptor agonists or antagonists had this effect.”

    From Glutamate receptors in domestication and modern human evolution (2020) · cites this paper as Scaccianoce et al., 2003

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Scaccianoce, S., Matrisciano, F., Del Bianco, P., Caricasole, A., Di Giorgi Gerevini, V., Cappuccio, I., Melchiorri, D., Battaglia, G., & Nicoletti, F.
Affiliations
  • Sapienza University of Rome (IT)
  • Siena Biotech (Italy) (IT)
  • Istituto Neurologico Mediterraneo (IT)
Corresponding author
Nicoletti, F.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2003-04
Volume
44
Issue
5
Pages
555-561
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2151934215
Cited by
54
References
29
Citations by year
2025: 1 · 2024: 2 · 2022: 2 · 2020: 1 · 2019: 2 · 2016: 1 · 2015: 4 · 2014: 2 · 2012: 4
FWCI
2.14
Type
journal article
Language
en
Open access
closed
Locations
  • Neuropharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Funders
Eli Lilly and Company
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
group II metabotropic glutamate receptors, mGlu2/3 receptors, hypothalamic-pituitary-adrenal axis, corticosterone, corticotropin-releasing factor, ACTH secretion, LY341495, LY379268, MPEP, mGlu5 receptor, anterior pituitary, hypothalamus
MeSH terms
Adrenal Glands, Animals, Corticosterone, Corticotropin-Releasing Hormone, Hypothalamo-Hypophyseal System, Hypothalamus, Male, Pituitary-Adrenal System, Receptors, Metabotropic Glutamate, Excitatory Amino Acid Agonists, Excitatory Amino Acid Antagonists, Mice, Rats, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review